Tags

Type your tag names separated by a space and hit enter

Endocannabinoid regulation of spinal nociceptive processing in a model of neuropathic pain.
Eur J Neurosci. 2010 Apr; 31(8):1414-22.EJ

Abstract

Models of neuropathic pain are associated with elevated spinal levels of endocannabinoids (ECs) and altered expression of cannabinoid receptors on primary sensory afferents and post-synaptic cells in the spinal cord. We investigated the impact of these changes on the spinal processing of sensory inputs in a model of neuropathic pain. Extracellular single-unit recordings of spinal neurones were made in anaesthetized neuropathic and sham-operated rats. The effects of spinal administration of the cannabinoid CB(1) receptor antagonist N-(piperidin-1-yl)-5-(4-iodophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (AM251) and the cannabinoid receptor type 2 (CB(2)) receptor antagonist N-[(1S)-endo-1,3,3-trimethylbicycloheptan-2-yl]-5-(4-chloro-3-methylphenyl)-1-(4-methylbenzyl)-pyrazole-3-carboxamide (SR144528) on mechanically-evoked responses of spinal neurones were determined. The effects of spinal administration of (5Z,8Z11Z,14Z)-N-(3-furanylmethyl)-5,8,11,14-eicosatetraenamide (UCM707), which binds to CB(2) receptors and alters transport of ECs, on evoked responses of spinal neurones and spinal levels of ECs were also determined. The cannabinoid CB(1) receptor antagonist AM251, but not the CB(2) receptor antagonist, significantly facilitated 10-g-evoked responses of spinal neurones in neuropathic, but not sham-operated, rats. Spinal administration of UCM707 did not alter spinal levels of ECs but did significantly inhibit mechanically-evoked responses of neurones in neuropathic, but not sham-operated, rats. Pharmacological studies indicated that the selective inhibitory effects of spinal UCM707 in neuropathic rats were mediated by activation of spinal CB(2) receptors, as well as a contribution from transient receptor potential vanilloid 1 (TRPV1) channels. This work demonstrates that changes in the EC receptor system in the spinal cord of neuropathic rats influence the processing of sensory inputs, in particular low-weight inputs that drive allodynia, and indicates novel effects of drugs acting via multiple elements of this receptor system.

Authors+Show Affiliations

School of Biomedical Sciences, University of Nottingham, Medical School, Queen's Medical Centre, Nottingham, UK. devi.sagar@nottingham.ac.ukNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

20384778

Citation

Sagar, Devi Rani, et al. "Endocannabinoid Regulation of Spinal Nociceptive Processing in a Model of Neuropathic Pain." The European Journal of Neuroscience, vol. 31, no. 8, 2010, pp. 1414-22.
Sagar DR, Jhaveri MD, Richardson D, et al. Endocannabinoid regulation of spinal nociceptive processing in a model of neuropathic pain. Eur J Neurosci. 2010;31(8):1414-22.
Sagar, D. R., Jhaveri, M. D., Richardson, D., Gray, R. A., de Lago, E., Fernández-Ruiz, J., Barrett, D. A., Kendall, D. A., & Chapman, V. (2010). Endocannabinoid regulation of spinal nociceptive processing in a model of neuropathic pain. The European Journal of Neuroscience, 31(8), 1414-22. https://doi.org/10.1111/j.1460-9568.2010.07162.x
Sagar DR, et al. Endocannabinoid Regulation of Spinal Nociceptive Processing in a Model of Neuropathic Pain. Eur J Neurosci. 2010;31(8):1414-22. PubMed PMID: 20384778.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Endocannabinoid regulation of spinal nociceptive processing in a model of neuropathic pain. AU - Sagar,Devi Rani, AU - Jhaveri,Maulik D, AU - Richardson,Denise, AU - Gray,Roy A, AU - de Lago,Eva, AU - Fernández-Ruiz,Javier, AU - Barrett,David A, AU - Kendall,David A, AU - Chapman,Victoria, Y1 - 2010/04/09/ PY - 2010/4/14/entrez PY - 2010/4/14/pubmed PY - 2010/9/29/medline SP - 1414 EP - 22 JF - The European journal of neuroscience JO - Eur. J. Neurosci. VL - 31 IS - 8 N2 - Models of neuropathic pain are associated with elevated spinal levels of endocannabinoids (ECs) and altered expression of cannabinoid receptors on primary sensory afferents and post-synaptic cells in the spinal cord. We investigated the impact of these changes on the spinal processing of sensory inputs in a model of neuropathic pain. Extracellular single-unit recordings of spinal neurones were made in anaesthetized neuropathic and sham-operated rats. The effects of spinal administration of the cannabinoid CB(1) receptor antagonist N-(piperidin-1-yl)-5-(4-iodophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (AM251) and the cannabinoid receptor type 2 (CB(2)) receptor antagonist N-[(1S)-endo-1,3,3-trimethylbicycloheptan-2-yl]-5-(4-chloro-3-methylphenyl)-1-(4-methylbenzyl)-pyrazole-3-carboxamide (SR144528) on mechanically-evoked responses of spinal neurones were determined. The effects of spinal administration of (5Z,8Z11Z,14Z)-N-(3-furanylmethyl)-5,8,11,14-eicosatetraenamide (UCM707), which binds to CB(2) receptors and alters transport of ECs, on evoked responses of spinal neurones and spinal levels of ECs were also determined. The cannabinoid CB(1) receptor antagonist AM251, but not the CB(2) receptor antagonist, significantly facilitated 10-g-evoked responses of spinal neurones in neuropathic, but not sham-operated, rats. Spinal administration of UCM707 did not alter spinal levels of ECs but did significantly inhibit mechanically-evoked responses of neurones in neuropathic, but not sham-operated, rats. Pharmacological studies indicated that the selective inhibitory effects of spinal UCM707 in neuropathic rats were mediated by activation of spinal CB(2) receptors, as well as a contribution from transient receptor potential vanilloid 1 (TRPV1) channels. This work demonstrates that changes in the EC receptor system in the spinal cord of neuropathic rats influence the processing of sensory inputs, in particular low-weight inputs that drive allodynia, and indicates novel effects of drugs acting via multiple elements of this receptor system. SN - 1460-9568 UR - https://www.unboundmedicine.com/medline/citation/20384778/Endocannabinoid_regulation_of_spinal_nociceptive_processing_in_a_model_of_neuropathic_pain_ L2 - https://doi.org/10.1111/j.1460-9568.2010.07162.x DB - PRIME DP - Unbound Medicine ER -